SBC Medical Group Holdings Incorporated Operating Expenses
SBC Medical Group Holdings Incorporated (SBC) reported Operating Expenses of $17.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated operating expenses for the quarter ending 2026-06-30 was $17.02M, a 10.10% increase year-over-year.
- SBC Medical Group Holdings Incorporated operating expenses for the quarter ending 2026-03-31 was $12.63M, a 6.68% decline year-over-year.
- SBC Medical Group Holdings Incorporated operating expenses for the quarter ending 2025-12-31 was $16.08M, a 44.85% decline year-over-year.
- SBC Medical Group Holdings Incorporated operating expenses for the quarter ending 2025-09-30 was $14.73M, a 49.90% decline year-over-year.
- SBC Medical Group Holdings Incorporated operating expenses for fiscal 2025 was $59.80M, a 30.26% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated operating expenses for fiscal 2024 was $85.75M, a 28.66% increase from fiscal 2023.
- SBC Medical Group Holdings Incorporated operating expenses for fiscal 2023 was $66.64M.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 4 month | Operating Expenses 4 month as first filed | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 10 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.02M 10-Q · filed 2026-08-13 | $29.64M 10-Q · filed 2026-08-13 | $45.72M derived: sum of 3 quarters · filed 2026-08-13 | $60.45M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2026-03-31 | $12.63M 10-Q · filed 2026-05-14 | $28.71M derived: sum of 2 quarters · filed 2026-05-14 | $43.44M derived: sum of 3 quarters · filed 2026-05-14 | $58.89M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-12-31 | $16.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $30.81M derived: sum of 2 quarters · filed 2026-03-27 | $46.27M derived: sum of 3 quarters · filed 2026-08-13 | $59.80M 10-K · filed 2026-03-27 | ||||||||
| 2025-09-30 | $14.73M 10-Q · filed 2025-11-14 | $30.19M derived: sum of 2 quarters · filed 2026-08-13 | $43.72M 10-Q · filed 2025-11-14 | $72.87M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-06-30 | $15.46M 10-Q · filed 2026-08-13 | $28.99M 10-Q · filed 2026-08-13 | $58.14M derived: sum of 3 quarters · filed 2026-08-13 | $87.55M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-03-31 | $13.53M 10-Q · filed 2026-05-14 | $42.69M derived: sum of 2 quarters · filed 2026-05-14 | $72.09M derived: sum of 3 quarters · filed 2026-05-14 | $84.22M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||
| 2024-12-31 | $29.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $58.56M derived: sum of 2 quarters · filed 2026-03-27 | $70.69M derived: sum of 3 quarters · filed 2026-03-27 | $85.75M 10-K · filed 2026-03-27 | ||||||||
| 2024-09-30 | $29.40M 10-Q · filed 2025-11-14 | $41.53M derived: sum of 2 quarters · filed 2025-11-14 | $56.59M 10-Q · filed 2025-11-14 | $75.97M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | $12.13M 10-Q · filed 2025-08-13 | $27.19M 10-Q · filed 2025-08-13 | $46.57M derived: sum of 3 quarters · filed 2025-08-13 | $60.04M derived: sum of 4 quarters · filed 2025-08-13 | ||||||||
| 2024-03-31 | $15.06M 10-Q · filed 2025-05-15 | $462.64K 10-Q · filed 2024-05-20 | $34.44M derived: sum of 2 quarters · filed 2025-05-15 | $47.91M derived: sum of 3 quarters · filed 2025-05-15 | $48.34M derived: sum of 4 quarters · filed 2025-05-15 | |||||||
| 2023-12-31 | $19.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $32.85M derived: sum of 2 quarters · filed 2025-03-28 | $33.28M derived: sum of 3 quarters · filed 2025-03-28 | $66.64M 10-K · filed 2025-03-28 | $1.64M 10-K · filed 2024-03-19 | |||||||
| 2023-09-30 | $13.48M 10-Q · filed 2024-11-13 | $282.92K 10-Q · filed 2023-11-14 | $13.91M derived: sum of 2 quarters · filed 2024-11-13 | $47.27M 10-Q · filed 2024-11-13 | $1.09M 10-Q · filed 2023-11-14 | |||||||
| 2023-06-30 | $430.84K 10-Q · filed 2023-08-14 | $805.33K 10-Q · filed 2023-08-14 | ||||||||||
| 2023-03-31 | $374.49K 10-Q · filed 2024-05-20 | |||||||||||
| 2022-12-31 | $382.05K 10-K · filed 2024-03-19 | |||||||||||
| 2022-09-30 | $177.87K 10-Q · filed 2023-11-14 | $179.15K derived: sum of 2 quarters · filed 2023-11-14 | $179.49K 10-Q · filed 2023-11-14 | |||||||||
| 2022-06-30 | $1.28K 10-Q · filed 2023-08-14 | $1.21K 10-Q · filed 2022-09-09 | $1.62K 10-Q · filed 2023-08-14 | $1.21K 10-Q · filed 2022-09-09 | ||||||||
| 2022-03-31 | $339.00 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |